| Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data | BMJ, The | 2014 | 406 |
| Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial | Journal of Hypertension | 1999 | 201 |
| Familial hypercholesterolaemia: a model of care for Australasia | Atherosclerosis Supplements | 2011 | 153 |
| Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis | Australian and New Zealand Journal of Psychiatry | 2012 | 152 |
| Non-adherence to statin therapy: a major challenge for preventive cardiology | Expert Opinion on Pharmacotherapy | 2009 | 93 |
| Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update | Nutrients | 2015 | 83 |
| Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation | Journal of Clinical Lipidology | 2014 | 79 |
| Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis | Stroke | 2013 | 70 |
| Implications of pulse pressure as a predictor of cardiac risk in patients with hypertension | Hypertension | 2000 | 67 |
| Magnesium in cardiac arrest (the magic trial) | Resuscitation | 1997 | 66 |
| Genetic analysis of familial hypercholesterolaemia in Western Australia | Atherosclerosis | 2012 | 56 |
| Revisiting the metabolic syndrome | Medical Journal of Australia | 2006 | 51 |
| A pilot randomized controlled trial of deprescribing | Therapeutic Advances in Drug Safety | 2011 | 50 |
| Cost effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a lifetime model | Pharmacoeconomics | 2007 | 50 |
| MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises? | Expert Opinion on Therapeutic Targets | 2007 | 49 |
| Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE) | Drugs and Aging | 2003 | 48 |
| Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in Western Australia | Heart Lung and Circulation | 2014 | 44 |
| A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia | International Journal of Cardiology | 2013 | 44 |
| Opportunistic screening for familial hypercholesterolaemia via a community laboratory | Annals of Clinical Biochemistry | 2012 | 44 |
| The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention | Nature Clinical Practice Cardiovascular Medicine | 2007 | 44 |
| Prevention of venous thromboembolism in patients admitted to Australian hospitals: summary of National Health and Medical Research Council clinical practice guideline | Internal Medicine Journal | 2012 | 39 |
| Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis | Medical Journal of Australia | 2011 | 36 |
| Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology | Heart Lung and Circulation | 2008 | 34 |
| Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and gender | PLoS ONE | 2013 | 33 |
| Familial hypercholesterolemia: a missed opportunity in preventive medicine | Nature Clinical Practice Cardiovascular Medicine | 2007 | 33 |
